Neonc Technologies Holdings (NTHI) Accumulated Expenses (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Accumulated Expenses of $1.7 million for Q1 2026, up 282.87% year-over-year from $444766.0 in Q1 2025, and up 128.54% quarter-over-quarter from $745118.0 in Q4 2025.
Neonc Technologies Holdings (NTHI) Accumulated Expenses (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Accumulated Expenses for 3 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses rose 282.87% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 282.87% YoY), while the FY2025 annual figure was $745118.0, up 1.39% from the prior year.
- Accumulated Expenses grew to $1.7 million in Q1 2026 per NTHI's latest filing, from $745118.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $1.7 million in Q1 2026 and bottomed at $255099.0 in Q2 2025.
- Historically, Accumulated Expenses has averaged $689638.8 across 3 years, with a median of $589820.0 in 2024.
- Annual changes were most pronounced in 2025 — Accumulated Expenses climbed 1.39% — and 2026, when it soared 282.87%.
- Neonc Technologies Holdings' Accumulated Expenses stood at $734874.0 in 2024, then climbed by 1.39% to $745118.0 in 2025, then soared by 128.54% to $1.7 million in 2026.
- Business Quant data shows NTHI's Accumulated Expenses at $1.7 million in Q1 2026, $745118.0 in Q4 2025, and $255099.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.05 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | 745,118.00 |
| Sep 30, 2025 | 255,099.00 |
| Jun 30, 2025 | 255,099.00 |
| Mar 31, 2025 | 444,766.00 |
| Dec 31, 2024 | 734,874.00 |